Navidea Biopharmaceuticals (NAVB) announces a distribution agreement with
Global Medical Solutions Taiwan for Lymphoseek.
NAVB says the deal builds "on the growth of Lymphoseek sales in the United States, which continue the positive trends recently reported."
The company says it will work with its partner to address Taiwanese regulatory requirements and expects "local approval in 2014-15," although Lymphoseek may be available prior to approval "in appropriate situations." (PR)